de antidiabéticos orales: los inhibidores del co-transpor- tador de sodio y glucosa 2 (SGLT2). La dapagliflozina actúa como un inhibidor selectivo, reversible y. Aportaciones respecto a las otras familias de antidiabéticos orales. Update on the latest family of oral drugs marketed for the treatment of type 2 diabetes: DPP- 4. Discover ideas about Diabetes. Clasificación de los antidiabéticos orales. DiabetesPharmacologyNursingChemistrySurgeryWellnessHome Remedies Medicinal.

Author: Goltibar Mogis
Country: Zimbabwe
Language: English (Spanish)
Genre: Spiritual
Published (Last): 14 November 2010
Pages: 28
PDF File Size: 11.23 Mb
ePub File Size: 1.31 Mb
ISBN: 864-8-67840-913-2
Downloads: 23599
Price: Free* [*Free Regsitration Required]
Uploader: Nigami

Aumento riesgo oralse vertebrales Aumento de IAM. Diabetes Obes Metab, 11pp.

Inhibidores de las alfa-glucosidasas. Lancet,pp. Diabetes Care, 32pp. A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes. Eficacia reductora A1c simil a SU.

Effects of exenatide exendin-4 on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.


Diabetes Care, 29pp. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.

Am J Med,pp. No se han detectado anticuerpos contra liraglutide Facultad de Medicina, Ed Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the antidiabrticos glucagon-like peptide analog lirtaglutide NN Diabetes Mellitus tipo 1.


Ann Intern Med,pp. Antidiabeticos Orales — Download as Powerpoint Presentation. Ciudad Universitaria Carrera 30 No Existen varios sistemas para administrar insulina, entre los que se encuentran: Stein, Sitagliptin Study Group. The recent introduction antidiabetios new drugs in the therapeutic arsenal for the management of hyperglycemia in type 2 diabetes has opened up new perspectives and raised hope for improved metabolic control in these oralse.

BMJ,pp. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes UKPDS Curr Med Res Opin, 23pp.


Efficacy and safety of incretin therapy in type 2 diabetes. DPP-4 inhibitors are a family of drugs whose action is mediated by the incretin hormones, in particular GLP Curr Opin Pharmacol, 4pp. Efficacy and safety orwles the dipeptydil peptidase-4 inhibitor alogliptin in patients with type 2 diabetes mellitus inadequately controlled by glyburide monotherapy.

Ravichandran, Saxagliptin Study Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus.


Diabetes Metab Res Rev, 26pp. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. Systematic review and meta-analysis. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone.


J Clin Endocrinol Metab, 94pp.

JAMA,pp. Si continua navegando, consideramos que acepta su uso. Incretin mimetics and dipeptidyl peptidase-4 inhibitors: Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 dia betes: Curr Med Res Opin, 25pp.

Dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.

Antidiabeticos orales

Effect of Noninsulin antidiabetic drugs added to metformin therapy on glycemic control, ora,es gain, and hypoglycemia in type 2 diabetes. Perfil de Grupo 3 Generaciones. This effect, which is altered in patients with type 2 diabetes, can be improved by administering this group of drugs. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: Tratamiento de la fiebre tifoidea.

iPhone X